U.S. FDA Grants Priority Review of New Drug Application for Gilead's Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir
Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
PEPFAR and The Global Fund Make Additional Investment in Gilead's Lenacapavir for HIV Prevention to Further Expand Access
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases
Element79 Gold Corp. Announces Postponement of Special Meeting of Securityholders in Connection with Previously Announced Plan of Arrangement with Synergy Metals Corp.
Juggernaut Mobilizes For Inaugural 10,000 Meter Drill Program to Test New District Scale High Grade Gold Silver Copper Rich Discovery at 100% Controlled Big One Property, Golden Triangle, B.C
